Literature DB >> 15974532

Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study.

Massimo Cimini1, Derek R Boughner, John A Ronald, Lori Aldington, Kem A Rogers.   

Abstract

BACKGROUND AND AIM OF THE STUDY: It has been suggested that aortic valve sclerosis (AVS) is an atherosclerotic disease process that can proceed to aortic stenosis. The absence of reports studying an animal model of the early stages of this disease has precluded the development of preventive therapeutic strategies. A cholesterol-fed (0.25% cholesterol in chow) rabbit model of atherosclerosis that is characterized by a moderate level of hypercholesterolemia was studied to determine its efficacy as a model of early AVS. Cellular, structural and morphological changes in the aortic valves of these rabbits were studied.
METHODS: Twenty rabbits were assigned randomly to four experimental groups: Group 1 received normal chow for 40 weeks; group 2 received 0.25% cholesterol-supplemented chow for 20 weeks; group 3 received 0.25% cholesterol-supplemented chow for 40 weeks; and group 4 received 0.25% cholesterol-supplemented chow for 20 weeks followed by normal chow for an additional 20 weeks. The aortas and aortic valves were analyzed using immunohistochemical and histological methods to detect cellular and structural components of the developing lesions.
RESULTS: All rabbits in groups 2, 3 and 4 developed atherosclerotic lesions in their aortas. Aortic valves from these animals demonstrated thickening, lipid deposition, a change in collagen content and organization, a reorganization of elastin, and the presence of both macrophage infiltrate and osteopontin.
CONCLUSION: These findings were consistent with the suggestion of a link between atherosclerosis and AVS. Results were also similar to changes reported in human sclerotic aortic valves, suggesting the suitability of this rabbit model of atherosclerosis as a model for AVS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974532

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  14 in total

Review 1.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

Review 2.  Calcific aortic valve disease: is it another face of atherosclerosis?

Authors:  I Sathyamurthy; Shaji Alex
Journal:  Indian Heart J       Date:  2015-08-21

3.  Calcific aortic stenosis: medical and surgical management in the elderly.

Authors:  Nalini M Rajamannan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-12

4.  Neurotrophin 3 upregulates proliferation and collagen production in human aortic valve interstitial cells: a potential role in aortic valve sclerosis.

Authors:  Qingzhou Yao; Rui Song; Lihua Ao; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Cell Physiol       Date:  2017-03-29       Impact factor: 4.249

Review 5.  Quantitative cardiovascular magnetic resonance for molecular imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-03       Impact factor: 5.364

Review 6.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

Review 7.  Calcific aortic stenosis: lessons learned from experimental and clinical studies.

Authors:  Nalini M Rajamannan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-20       Impact factor: 8.311

Review 8.  Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?

Authors:  Nalini M Rajamannan; Francesco Antonini-Canterin; Luis Moura; Jose L Zamorano; Raphael A Rosenhek; Patricia Jm Best; Margaret A Lloyd; F Rocha-Goncalves; Sarat Chandra; Ottavio Alfieri; Patrizio Lancellotti; Pilar Tornos; Ragavendra R Baliga; Andrew Wang; Thomas Bashore; S Ramakrishnan; Konstantinos Spargias; Mony Shuvy; Ronen Beeri; Chaim Lotan; Jassim Al Suwaidi; Vinay Bahl; Luc A Pierard; Gerald Maurer; Gian Luigi Nicolosi; Shahbudin H Rahimtoola; K Chopra; Natesa G Pandian
Journal:  Indian Heart J       Date:  2009 Jan-Feb

9.  Animal models of calcific aortic valve disease.

Authors:  Krista L Sider; Mark C Blaser; Craig A Simmons
Journal:  Int J Inflam       Date:  2011-08-02

10.  Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS.

Authors:  Emily A Waters; Junjie Chen; John S Allen; Huiying Zhang; Gregory M Lanza; Samuel A Wickline
Journal:  J Cardiovasc Magn Reson       Date:  2008-09-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.